Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Comment by Alba1314on Aug 27, 2018 10:46am
52 Views
Post# 28521994

RE:RE:RE:RE:RE:RE:RE:RE:What I do Like

RE:RE:RE:RE:RE:RE:RE:RE:What I do Likepositive trial results do that. usually settles down below its peak but higher then before then run. Lots of times you see a run up before the results are even released and then a pull back afterwards even if the results are positive (the old "buy on rumour, sell on news" at work. This time the run up continued.

I think the possibility of the 32M in milestone payments may have had something to do with as well. There's your p&d at work there. Those payments are based on royalties on sales, not progression through trials. IMNP had a positive trial result so people started pumping the milestone payments. I'll admit I didnt know they were on sales till iCo released some docs on SEDAR last month. Tried to find out prior to that what they were based on but no luck. I think a lot people bought into that hype.




<< Previous
Bullboard Posts
Next >>